Stock Ideas
New
Stocks
Funds
Screener
Sectors
Watchlists
PBH

PBH - Prestige Consumer Healthcare Inc Stock Price, Fair Value and News

64.86USD-1.32 (-1.99%)Market Closed

Market Summary

PBH
USD64.86-1.32
Market Closed
-1.99%

PBH Alerts

  • Big jump in Earnings (Y/Y)

PBH Stock Price

View Fullscreen

PBH RSI Chart

PBH Valuation

Market Cap

3.2B

Price/Earnings (Trailing)

15.47

Price/Sales (Trailing)

2.88

EV/EBITDA

18.02

Price/Free Cashflow

13.52

PBH Price/Sales (Trailing)

PBH Profitability

Operating Margin

55.49%

EBT Margin

24.53%

Return on Equity

12.65%

Return on Assets

6.31%

Free Cashflow Yield

7.39%

PBH Fundamentals

PBH Revenue

Revenue (TTM)

1.1B

Rev. Growth (Yr)

-3.11%

Rev. Growth (Qtr)

-2.03%

PBH Earnings

Earnings (TTM)

209.3M

Earnings Growth (Yr)

120.56%

Earnings Growth (Qtr)

-6.76%

Breaking Down PBH Revenue

Last 7 days

0.1%

Last 30 days

-9.2%

Last 90 days

-13.1%

Trailing 12 Months

13.2%

How does PBH drawdown profile look like?

PBH Financial Health

Current Ratio

3.2

Debt/Equity

0.68

Debt/Cashflow

0.22

PBH Investor Care

Shares Dilution (1Y)

0.45%

Diluted EPS (TTM)

4.17

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20241.1B000
20231.1B1.1B1.1B1.1B
20221.1B1.1B1.1B1.1B
2021943.4M983.2M1.0B1.1B
2020963.0M960.3M959.6M956.8M
2019975.8M954.0M952.7M952.8M
20181.0B1.0B1.0B990.7M
2017882.1M929.1M972.0M1.0B
2016806.2M823.7M832.7M849.2M
2015714.6M761.1M785.8M788.4M
2014597.4M600.6M614.9M667.6M
2013623.6M619.1M624.2M608.8M
2012441.1M492.8M549.1M603.1M
2011333.7M357.8M385.0M400.7M
2010292.6M302.9M313.2M323.4M
GRUFITY'S FAIR VALUE MODEL

Stocks Marked 'Very Cheap' by Grufity's Fair Value Model Have Outperformed Russell 2000 Index

Small Caps and Mid Caps are mostly overlooked by investors as all the focus goes to Magnificent 7. These stocks that are not part of the beauty contest require a deeper look. However, all large cap stocks were once small caps. Grufity's Fair Value model opens up this unverse as it separates high-performing, rewarding stocks from low-performing risky stocks. <b>Russell 2000 stocks that were marked 'Very Cheap' by the model doubled in three years while the index was flat.</b>

PurpleZone


Returns of $10,000 invested in:

Very Cheap Stocks: $21,859
Russell 2000 Index: $10,334
Very Expensive Stocks: $8,224


Russell 2000 stocks considered 'Very Cheap' by the model greatly outperformed Russell 2000 index and the 'Very Expensive' bucket over past three years.

Russell 2000 Index
Very Expensive Stocks
Very Cheap Stocks
Try For Just $1.99

Tracking the Latest Insider Buys and Sells of Prestige Consumer Healthcare Inc

Filter Transactions
Datesorted ascendingNameBuy/Sell$ ValueAvg. Price# SharesTitle
May 07, 2024
p'pool william
acquired
-
-
3,123
see remarks
May 07, 2024
mekhail adel
acquired
-
-
3,020
evp, marketing & sales
May 07, 2024
sacco christine
acquired
-
-
6,062
chief financial officer
May 07, 2024
lombardi ronald m.
acquired
-
-
14,298
chief executive officer
May 07, 2024
zerillo jeffrey
acquired
-
-
2,116
senior vp operations
May 07, 2024
fritz mary beth
acquired
-
-
2,042
svp quality & regulatory
May 06, 2024
p'pool william
sold (taxes)
-206,220
70.00
-2,946
see remarks
May 06, 2024
fritz mary beth
acquired
-
-
3,456
svp quality & regulatory
May 06, 2024
lombardi ronald m.
acquired
-
-
85,533
chief executive officer
May 06, 2024
sacco christine
sold (taxes)
-375,410
70.00
-5,363
chief financial officer

1–10 of 50

Which funds bought or sold PBH recently?

View All Details
Datesorted ascendingFund NameType% Chg$ Change$ Held% Portfolio
Jun 11, 2024
EverSource Wealth Advisors, LLC
added
80.62
17,646
33,441
-%
Jun 06, 2024
WESTWOOD HOLDINGS GROUP INC
reduced
-19.35
-3,037,000
65,830,000
0.52%
May 28, 2024
TEACHERS RETIREMENT SYSTEM OF THE STATE OF KENTUCKY
unchanged
-
181,000
1,159,000
0.01%
May 22, 2024
BURNEY CO/
reduced
-22.92
-105,220
1,112,600
0.04%
May 21, 2024
Atria Investments, Inc
new
-
1,246,440
1,246,440
0.02%
May 20, 2024
EMC Capital Management
reduced
-12.72
17,000
513,000
0.31%
May 16, 2024
JANE STREET GROUP, LLC
reduced
-47.00
-489,696
827,329
-%
May 16, 2024
Virtus Investment Advisers, Inc.
unchanged
-
253,596
1,622,660
1.16%
May 16, 2024
CALIFORNIA STATE TEACHERS RETIREMENT SYSTEM
reduced
-4.7
414,870
3,617,040
-%
May 16, 2024
COMERICA BANK
reduced
-18.99
-173,568
4,184,840
0.02%

1–10 of 48

Are Funds Buying or Selling PBH?

Are funds buying PBH calls or puts?
Calls
Puts
No. of funds holding Calls - Puts
Net Call Options
No. of funds that own PBH
No. of Funds

Unveiling Prestige Consumer Healthcare Inc's Major ShareHolders

Date FiledName of FilerPercent of ClassNo. of SharesForm Type
Feb 14, 2024
macquarie group ltd
6.17%
3,062,581
SC 13G
Feb 14, 2024
ariel investments, llc
5.2%
2,555,777
SC 13G
Feb 13, 2024
vanguard group inc
11.60%
5,756,138
SC 13G/A
Feb 09, 2024
dimensional fund advisors lp
6.9%
3,434,500
SC 13G/A
Jan 19, 2024
blackrock inc.
18.3%
9,067,957
SC 13G/A
Feb 10, 2023
dimensional fund advisors lp
7.4%
3,674,930
SC 13G/A
Feb 09, 2023
vanguard group inc
11.61%
5,748,791
SC 13G/A
Jan 23, 2023
blackrock inc.
19.0%
9,407,577
SC 13G/A
Feb 08, 2022
dimensional fund advisors lp
6.9%
3,435,736
SC 13G/A
Jan 28, 2022
blackrock inc.
16.2%
8,111,381
SC 13G/A

Recent SEC filings of Prestige Consumer Healthcare Inc

View All Filings
Date Filed Form Type Document
May 15, 2024
10-K
Annual Report
May 14, 2024
8-K
Current Report
May 09, 2024
4
Insider Trading
May 09, 2024
4
Insider Trading
May 09, 2024
4
Insider Trading
May 09, 2024
4
Insider Trading
May 09, 2024
4
Insider Trading
May 09, 2024
4
Insider Trading
May 08, 2024
4
Insider Trading
May 08, 2024
4
Insider Trading

Peers (Alternatives to Prestige Consumer Healthcare Inc)

NameMkt Capsorted ascendingRevenuePrice %, 1MReturns, 1YP/EP/SRev 1-YrInc 1-Yr
LARGE-CAP
350.0B
85.6B
-3.94% -10.00%
9.1
4.09
5.68% 202.39%
327.6B
61.4B
0.54% 19.05%
142.08
5.34
6.11% -82.30%
160.0B
29.5B
-4.21% 34.20%
42.52
5.42
12.76% -52.47%
156.6B
35.0B
-2.61% -29.78%
134.79
4.47
-26.40% -92.03%
79.1B
27.4B
-6.10% -18.51%
163.34
2.88
1.51% -91.32%
19.5B
16.0B
1.81% 133.24%
-39.52
1.22
7.23% 71.10%
MID-CAP
4.2B
1.7B
1.31% -21.88%
9.66
2.43
54.01% 364.56%
3.7B
4.6B
-9.61% -18.87%
-484.73
0.82
-0.06% 94.55%
2.3B
9.0B
-13.20% -15.57%
-4.98
0.25
10.01% -27.45%
2.0B
676.2M
-1.62% -15.25%
12.84
2.94
30.38% 66.04%
SMALL-CAP
1.3B
743.2M
-16.75% 6.10%
-3.83
1.81
24.65% 80.36%
22.8M
1.3M
-2.94% -47.62%
-3.08
17.54
-98.14% -104.71%
16.7M
89.6M
-19.67% -19.01%
-1.17
0.19
287.27% -129.41%
2.5M
21.5M
-5.26% -89.66%
-0.32
0.11
66.16% 61.84%
347.8K
115.7M
-61.54% -97.23%
0
0
-2.22% -352.48%

Prestige Consumer Healthcare Inc News

Latest updates
Defense World15 hours ago
Zacks Investment Research16 May 202407:00 am

Prestige Consumer Healthcare Inc Earnings Report: Key Takeaways & Analysis

Income Statement (Last 12 Months)
(In Millions)
Income Statement (Quarterly)
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Revenue-2.0%277283286279286276289277267274276269238239237229251242238232241
Cost Of Revenue0.3%12512512612513212512811711811911911010110010096.0010710410198.00103
Gross Profit-3.9%152158160155154150161160149155158159137139138134144137137134138
Operating Expenses-2.0%70.0071.0072.0069.0043563.0077.0073.0071.0072.0079.0068.0066.0065.0065.0054.0070.0061.0067.0063.00292
  S&GA Expenses1.8%26.0026.0026.0028.0028.0027.0026.0027.0027.0026.0032.0022.0021.0021.0020.0020.0024.0021.0023.0022.0021.00
EBITDA Margin-0.21*-0.00*0.00*0.01*0.32*0.32*0.33*0.33*0.31*0.32*0.33*0.34*--------
Interest Expenses7.9%-15.26-16.57-17.61-17.72-18.98-17.92-16.98-15.29-15.97-16.92-16.31-15.08146-20.14-21.27-21.94145-24.27-24.4825.0026.00
Income Taxes8.1%18.0017.0017.0015.00-58.9716.0016.0016.009.0015.0014.0019.005.0013.007.0014.0013.0012.0011.0012.00-39.76
Earnings Before Taxes-------------59.00---51.0051.0044.0046.00-179
EBT Margin-0.25*--0.08*-0.08*-0.08*0.24*0.24*0.24*0.24*0.19*0.20*0.21*0.22*--------
Net Income-6.8%49.0053.0054.0053.00-24052.0051.0055.0052.0050.0045.0058.0036.0041.0045.0044.0037.0038.0033.0034.00-139
Net Income Margin361.5%0.19*-0.07*-0.07*-0.07*-0.07*0.19*0.19*0.19*0.19*0.18*0.18*0.18*---------
Free Cashflow-8.2%64.0069.0060.0047.0056.0053.0055.0057.0060.0064.0058.0068.00---------
Balance Sheet
(In Millions)
Balance Sheet
(In Millions)
(*) denotes actual numbers (not divided by Millions)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Assets-0.6%3,3183,3403,3333,3463,3543,7503,6793,6823,6713,6593,6763,5593,4293,4693,4343,4503,5143,4643,4653,4613,441
  Current Assets-4.8%375394388392392409337325293275305409270301270296366300305311301
    Cash Equivalents-27.0%46.0064.0060.0055.0058.0086.0042.0036.0027.0021.0043.0016432.0062.0027.0058.0095.0029.0028.0029.0028.00
  Inventory-6.7%139149161170162159141134120106108106115117114117116121126129120
  Net PPE8.7%77.0070.0071.0070.0070.0070.0070.0070.0071.0070.0070.0070.0070.0069.0065.0058.0056.0053.0053.0051.0051.00
  Goodwill0.0%5285285275275285775765775795795791.00578580578577575578578578579
Liabilities-4.4%1,6631,7391,7971,8651,9072,0632,0592,0972,0932,1412,2142,1432,0712,1462,1562,2232,3432,3082,3522,3592,345
  Current Liabilities-8.2%117127130147161160152155143135149125122126136132150149147143127
  Long Term Debt-6.1%1,1261,1991,2631,3171,3461,4241,4381,4721,4771,5301,5931,5451,4801,5491,5481,6211,7301,7011,7541,7791,799
    LT Debt, Current-----------6.00----------
    LT Debt, Non Current-1,126---1,346---1,477--1,5451,4801,5491,5481,6211,7301,7011,7541,7791,799
Shareholder's Equity3.4%1,6551,6011,5361,4801,4471,6871,6201,5851,5781,5181,4621,4161,3581,3231,2781,2271,1711,1561,1131,1021,096
  Retained Earnings3.8%1,3411,2921,2391,1851,1321,3721,3201,2691,2141,1621,1121,0671,009973932888844807769736702
  Additional Paid-In Capital2.0%567556552547535533524521516513507504500495494491488486484481479
Shares Outstanding0.0%50.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.0050.00---------
Float---2,816---2,452---2,799---1,821---1,738--
Cashflow (Last 12 Months)
(In Thousands)
Cashflow (Quarterly)
(In Thousands)
(*) denotes actual numbers (not divided by Thousands)
Description(%) Q/Q2024Q12023Q42023Q32023Q22023Q12022Q42022Q32022Q22022Q12021Q42021Q32021Q22021Q12020Q42020Q32020Q22020Q12019Q42019Q32019Q22019Q1
Cashflow From Operations-6.4%66,90771,47262,46048,08758,98754,94257,54058,24763,12666,29761,19469,30559,08749,22752,13975,15456,12657,99850,22352,77750,847
  Share Based Compensation52.2%3,7272,4493,6884,1462,6492,4333,4663,8571,7082,2343,2191,8782,5991,5882,8921,4641,9621,7802,5211,3811,278
Cashflow From Investing-233.7%-15,004-4,496-2,9342,323-6,358-1,803-2,376-1,047-3,293-20,229-231,666-1,323-4,896-5,728-9,066-2,553-8,265-2,483-3,866-1,956-3,341
Cashflow From Financing-5.6%-68,444-64,843-53,549-54,179-80,495-10,021-47,956-47,374-54,115-67,63850,53463,650-83,709-9,044-75,304-111,36220,557-55,676-47,022-49,290-45,000
  Buy Backs----25,000--12,27337,727----1,9938,877997-6,745-21,21028,766-
Get Full Access to Grufity – and Unlimited Downloads
Gain full access to fair value, watchlists, stock screener, unlimited page visits, and additional features by joining as a member today for just $1.99.
Try For Just $1.99

PBH Income Statement

2024-03-31
Consolidated Statements of Income (Loss) and Comprehensive Income (Loss) - USD ($)
shares in Thousands, $ in Thousands
12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Revenues   
Total revenues$ 1,125,357$ 1,127,725$ 1,086,812
Cost of Sales   
Cost of sales excluding depreciation492,786494,883458,942
Cost of sales depreciation8,1237,5487,224
Cost of sales500,909502,431466,166
Gross profit624,448625,294620,646
Operating Expenses   
Advertising and marketing153,315145,061157,343
General and administrative106,152107,354107,459
Depreciation and amortization22,55225,07724,868
Goodwill and tradename impairment0370,2171,057
Total operating expenses282,019647,709290,727
Operating income (loss)342,429(22,415)329,919
Other expense (income)   
Interest expense, net67,16069,16464,287
Loss on extinguishment of debt002,122
Other (income) expense, net(756)2,3361,052
Total other expense, net66,40471,50067,461
Income (loss) before income taxes276,025(93,915)262,458
Provision (benefit) for income taxes66,686(11,609)57,077
Net income (loss)$ 209,339$ (82,306)$ 205,381
Earnings (loss) per share:   
Basic (in USD per share)$ 4.21$ (1.65)$ 4.09
Diluted (in USD per share)$ 4.17$ (1.65)$ 4.04
Weighted average shares outstanding:   
Basic (in shares)49,75749,88950,259
Diluted (in shares)50,17849,88950,842
Comprehensive income (loss), net of tax:   
Currency translation adjustments$ (2,940)$ (12,076)$ (1,296)
Unrealized gain on interest rate swaps001,819
Unrecognized net gain on pension plans9334246
Net loss on termination of pension plan0(790)0
Total other comprehensive (loss) income(2,931)(12,532)769
Comprehensive income (loss)206,408(94,838)206,150
Net sales   
Revenues   
Total revenues1,125,0461,127,6181,086,770
Other revenues   
Revenues   
Total revenues$ 311$ 107$ 42

PBH Balance Sheet

2024-03-31
Consolidated Balance Sheets - USD ($)
$ in Thousands
Mar. 31, 2024
Mar. 31, 2023
Current assets  
Cash and cash equivalents$ 46,469$ 58,489
Accounts receivable, net of allowance of $16,377 and $20,205, respectively176,775167,016
Inventories138,717162,121
Prepaid expenses and other current assets13,0824,117
Total current assets375,043391,743
Property, plant and equipment, net76,50770,412
Operating lease right-of-use assets11,28514,923
Finance lease right-of-use assets, net1,5414,200
Goodwill527,733527,553
Intangible assets, net2,320,5832,341,893
Other long-term assets5,7253,005
Total Assets3,318,4173,353,729
Current liabilities  
Accounts payable38,97962,743
Accrued interest payable15,76315,688
Operating lease liabilities, current portion4,6586,926
Finance lease liabilities, current portion1,4942,834
Other accrued liabilities56,15472,524
Total current liabilities117,048160,715
Long-term debt, net1,125,8041,345,788
Deferred income tax liabilities403,596380,434
Long-term operating lease liabilities, net of current portion7,5289,876
Long-term finance lease liabilities, net of current portion1721,667
Other long-term liabilities9,1858,165
Total Liabilities1,663,3331,906,645
Commitments and Contingencies – Note 18
Stockholders’ Equity  
Preferred stock – $0.01 par value; Authorized – 5,000 shares; Issued and outstanding – None00
Common stock – $0.01 par value; Authorized – 250,000 shares; Issued – 55,501 shares at March 31, 2024 and 54,857 shares at March 31, 2023555548
Additional paid-in capital567,448535,356
Treasury stock, at cost – 5,680 shares at March 31, 2024 and 5,165 shares at March 31, 2023(219,621)(189,114)
Accumulated other comprehensive loss, net of tax(34,495)(31,564)
Retained earnings1,341,1971,131,858
Total Stockholders’ Equity1,655,0841,447,084
Total Liabilities and Stockholders’ Equity$ 3,318,417$ 3,353,729
PBH
Prestige Consumer Healthcare Inc., together with its subsidiaries, develops, manufactures, markets, distributes, and sells over-the-counter (OTC) health and personal care products in the United States and internationally. The company operates in two segments, North American OTC Healthcare and International OTC Healthcare. It offers BC/Goody's analgesic powders, Boudreaux's Butt Paste baby ointments, Chloraseptic sore throat liquids and lozenges, Clear Eyes for eye redness relief, Compound W wart removals, DenTek for PEG oral care, Debrox ear wax removals, and Dramamine for motion sickness relief. The company also provides Fleet adult enemas/suppositories, Gaviscon upset stomach remedies, Luden's cough drops, Monistat vaginal anti-fungal, Nix lice/parasite treatments, Summer's Eve feminine hygiene, TheraTears dry eye relief, Fess nasal saline spray and washes, and Hydralyte for oral rehydration products. It sells its products through mass merchandisers; and drug, food, dollar, convenience, and club stores, as well as e-commerce channels. The company was formerly known as Prestige Brands Holdings, Inc. and changed its name to Prestige Consumer Healthcare Inc. in August 2018. Prestige Consumer Healthcare Inc. was founded in 1996 and is headquartered in Tarrytown, New York.
 CEO
 WEBSITEprestigebrands.com
 INDUSTRYPharmaceuticals
 EMPLOYEES560

Prestige Consumer Healthcare Inc Frequently Asked Questions


What is the ticker symbol for Prestige Consumer Healthcare Inc? What does PBH stand for in stocks?

PBH is the stock ticker symbol of Prestige Consumer Healthcare Inc. Every public company that trades on a stock exchange gets a ticker symbol.

What is the market capital of Prestige Consumer Healthcare Inc (PBH)?

As of Thu Jun 13 2024, market cap of Prestige Consumer Healthcare Inc is 3.24 Billion. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

What is the fair value of PBH stock?

You can check PBH's fair value in chart for subscribers.

What is the fair value of PBH stock?

You can check PBH's fair value in chart for subscribers. The fair value of Prestige Consumer Healthcare Inc is provided for various growth and macro-economic scenarios from very pessimiatic to very optimistic assumptions. These fair values are estimates from Grufity's Fair Value model based on company's past performance. However, past performance of Prestige Consumer Healthcare Inc is no guarantee of future performance. These fairvalue estimates should only be used as one of the inputs in your stock analysis. We provide model's historical fair value estimates for PBH so that you know how good or bad the model has been in the past so you can discard it if needed. There are others that provide fair values of stocks such as wallmine, finbox, gurufocus and finviz. Most provide point in time estimates. We provide a history of our models fair value estimates so that you can get a sense of it's usefulness. Otherwise this data point is of little use.

Is Prestige Consumer Healthcare Inc a good stock to buy?

The fair value guage provides a quick view whether PBH is over valued or under valued. Whether Prestige Consumer Healthcare Inc is cheap or expensive depends on the assumptions which impact Prestige Consumer Healthcare Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for PBH.

What is Prestige Consumer Healthcare Inc's Price to Earnings (PE) and Price to sales (PS) ratio?

As of Thu Jun 13 2024, PBH's PE ratio (Price to Earnings) is 15.47 and Price to Sales (PS) ratio is 2.88. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. PBH PE ratio will change depending on the future growth rate expectations of investors.

What is 5 year return on Prestige Consumer Healthcare Inc's stock?

In the past 10 years, Prestige Consumer Healthcare Inc has provided 0.069 (multiply by 100 for percentage) rate of return.